bromocriptine has been researched along with erythrosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nitsche, C; Voss, S | 1 |
| Freed, WJ; Kishikawa, M; Takashima, H; Tsujihata, M | 1 |
| Hamada, A; Kawaguchi, T; Nakano, M; Ohmura, T; Okamura, K; Shiraki, N; Tokunaga, J; Yasuda, K | 1 |
1 review(s) available for bromocriptine and erythrosine
| Article | Year |
|---|---|
Inhibitors of the Zika virus protease NS2B-NS3.
Topics: Animals; Antiviral Agents; Drug Discovery; Drug Repositioning; Humans; Serine Endopeptidases; Serine Proteinase Inhibitors; Viral Proteins; Zika Virus; Zika Virus Infection | 2020 |
2 other study(ies) available for bromocriptine and erythrosine
| Article | Year |
|---|---|
Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Antisense Elements (Genetics); Autoreceptors; Bromocriptine; Cell Survival; Cells, Cultured; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Fetus; Fluoresceins; Free Radicals; Gene Expression; Levodopa; Mesencephalon; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sulpiride; Tyrosine 3-Monooxygenase | 1999 |
Bromocriptine reverses P-glycoprotein-mediated multidrug resistance in tumor cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bromocriptine; Cell Line; Dopamine Agonists; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Humans; Rhodamine 123; Swine | 2002 |